Upperton Pharma Solutions, a contract development and manufacturing organisation has announced the successful completion of a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned 50,000 sqft development and GMP manufacturing facility in Nottingham, UK.
This milestone inspection, conducted by the UK Government’s regulatory authority, marks a significant achievement for Upperton Pharma Solutions following the completion of the build, commissioning, validation and approval of the facility in just 18 months.